APA (7th ed.) Citation

Guan, F., Ju, X., Chen, L., Ren, J., Ke, X., Luo, B., . . . Yuan, J. (2024). Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer. Diagnostic Pathology, 19(1), 1. https://doi.org/10.1186/s13000-024-01557-3

Chicago Style (17th ed.) Citation

Guan, Feng, Xianli Ju, Lixia Chen, Jiacai Ren, Xiaokang Ke, Bin Luo, Aoling Huang, and Jingping Yuan. "Comparison of Clinicopathological Characteristics, Efficacy of Neoadjuvant Therapy, and Prognosis in HER2-low and HER2-ultralow Breast Cancer." Diagnostic Pathology 19, no. 1 (2024): 1. https://doi.org/10.1186/s13000-024-01557-3.

MLA (9th ed.) Citation

Guan, Feng, et al. "Comparison of Clinicopathological Characteristics, Efficacy of Neoadjuvant Therapy, and Prognosis in HER2-low and HER2-ultralow Breast Cancer." Diagnostic Pathology, vol. 19, no. 1, 2024, p. 1, https://doi.org/10.1186/s13000-024-01557-3.